Electrogastrography in Small for Gestational Age Preterm Infants - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

January 8, 2009

Last Updated Date

January 8, 2009

Start Date ^†

June 2008

Current Primary Outcome Measures ^†

EGG compatible with age [ Time Frame: day 1 and day 7 after birth ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^†

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Electrogastrography in Small for Gestational Age Preterm Infants

Official Title ^†

Electrogastrography in Small for Gestational Age Preterm Infants Compared to Appropriate for Gestational Age Infants

Brief Summary

The purpose of this study is to determine whether small for gestational preterm infants, have delayed or decrease gastric motility compared to appropriate for gestational age preterm infants.

Detailed Description

Study Phase

Study Type ^†

Observational

Study Design ^†

Cohort, Prospective

Condition ^†

Premature Birth

Intervention ^†

Study Arms / Comparison Groups

Small for gestational age preterm infants
Appropriate for gestational preterm infants

Publications *

Liang J, Co E, Zhang M, Pineda J, Chen JD. Development of gastric slow waves in preterm infants measured by electrogastrography. Am J Physiol. 1998 Mar;274(3 Pt 1):G503-8.

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Recruiting

Estimated Enrollment ^†

Completion Date

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

preterm infants 32-37 weeks' gestation
No sepsis or ventilation
Feeding orally or with NG tube.
Age <48 h to be included

Exclusion Criteria:

GE reflux
Medication that affect gastric motility

Gender

Both

Ages

up to 2 Days

Accepts Healthy Volunteers

Contacts ^††

Contact: Shmuel Arnon, MD

972-9-7472225

shmuelar@clalit.org.il

Location Countries ^†

Israel

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00819715

Responsible Party

Mrs. Leah Cohen, Meir Medical Center

Secondary IDs ^††

Study Sponsor ^†

Meir Medical Center

Collaborators ^††

Investigators ^†

Principal Investigator:

Shmuel Arnon, MD

Meir Medical Center

Information Provided By

Meir Medical Center

Verification Date

January 2009

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.